ENTITY
Lupin

Lupin (LPC IN)

279
Analysis
Health Care • India
Lupin is an Indian multinational pharmaceutical company that develops, manufactures, and markets a diverse range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company specializes in therapeutic areas such as cardiovascular, anti-diabetic, respiratory, anti-infective, and women's health. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
more
bearish•Lupin
•09 Sep 2022 20:32

Lupin Ltd (LPC IN): Muted Q1FY23 Results as The US Sales Dipped Significantly

Lupin’s US business dipped significantly in Q1, due to price erosion, paring down inventories to normalized levels, and product rationalization....

Logo
481 Views
Share
•02 Sep 2022 07:05

NIFTY NEXT50 Index Rebalance: Significant Impact for an Overlooked Index

There are 7 adds/deletes for the NIFTY NEXT50 Index. The adds have outperformed the deletes but there are significant days of delivery volume to...

Logo
771 Views
Share
•21 Jul 2022 10:20

NIFTY100 Index Rebalance Preview: Couple of Changes in August, Then 5 More in September

There are two index changes at the close on 5 August, then there should be 5 more at the close on 29 September. Passive funds will have over 4-5...

Logo
730 Views
Share
•12 Jul 2022 10:08

NIFTY100 & CPSE Index Rebalance: Some Big Changes in 3 Weeks

LIC and Tata Power will be added to the NIFTY100 Index at the close on 5 August. NMDC is being deleted from the NIFTY100 & CPSE indices. There is a...

Logo
722 Views
Share
•22 May 2022 17:54

Dr. Reddy's Laboratories (DRRD IN) 4QFY22: Double-Digit Sales Growth; One-Off Charge Impacted Profit

Dr. Reddy’s reported strong double-digit revenue growth in Q4, while one-off charges weighed on bottom-line. New product launches in the U.S....

Logo
465 Views
Share
x